Propanc Biopharma Free Cash Flow (FCF) History (PPCB)

Propanc Biopharma reported −$2.1M in free cash flow for fiscal 2019.

View full Propanc Biopharma company overview

Propanc Biopharma free cash flow by year

Propanc Biopharma annual free cash flow

Fiscal yearPeriod endedFree cash flowChangeGrowthFCF margin
20192019-06-30−$2.1M———
20162016-06-30−$4.5M−$3.1M——
20152015-06-30−$1.4M−$1.7M——
20142014-06-30$226,442———
20112011-06-30−$1.4M———

Propanc Biopharma free cash flow growth trends

Over the last five reported fiscal years, free cash flow declined from $226,442 to −$2.1M, a net decrease of $2.3M. Propanc Biopharma's latest reported quarter, Q3 2026, generated −$1.1M in free cash flow.

About the metric

What free cash flow means

Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.

Calculation and source

How free cash flow is calculated

TickerStat calculates free cash flow as reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.

Review Propanc Biopharma source filings ↗

Community posts

It’s quiet here.

No posts about PPCB yet. Start the conversation.

Write the first post